USC’s research benefits society through innovations in health, the environment, security and energy supply. We also create sound, interactive media and visualization technology that is being used in movies, television and gaming. The resources below are available to USC innovators and to those who wish to work with USC innovators. Also, visit our featured innovations page.
Research at leading universities like the University of Southern California is measured both in its creativity and in its impact on society. Toward this end, the USC Stevens Center for Innovation was created to pioneer a university-wide, strategic approach to innovation. Its mission is to help USC innovators make maximum impact with their ideas. USC Stevens has been designated the university’s intellectual property authority and the central resource for technology transfer and licensing. It supports the university by forging ties with industry and investors, preparing faculty and students to transfer research into practical applications, and helping to create business strategies that build success.
Research Commercialization and SBIR Center (workshops on tech transfer and commercialization for faculty)
USC’s Intellectual Policy Property articulates the University’s strong desire to support creative activity, to encourage open dissemination of ideas, and to recognize and reward faculty, staff and student inventors and authors. The policy confirms the University’s ownership rights under law, but also recognizes exceptions that preserve the academic tradition of faculty ownership of certain scholarly works, similar to the practices at many comparable research universities. Under this policy, faculty, staff and students have more rights to own benefit from the intellectual property they create than they would otherswise be afforded under California law.
USC is working to translate its discoveries in medical research into clinical practice. This is accomplished through its partnership with Health Research Association (which coordinates clinical testing), through active engagement of the public through programs in preventive medicine, and through work being done at the SC CTSI.
The Alfred E. Mann Institute at the University of Southern California is a non-profit organization that supports research, development and commercialization of biomedical devices and other technologies. The Institute provides philanthropic support for biomedical device development that can significantly impact healthcare. It is a development center devoted to accelerating the commercialization of biomedical devices by nurturing promising biomedical technologies.
Blackstone Launchpad pairs students with consultants to help them develop their business ideas. As their ideas mature, students are connected to venture coaches to help them bring their ideas to market.
The USC Coulter Translational Research Partnership Program supports and funds projects that develop technologies to solve an unmet or underserved clinical need. The USC Coulter Program supports project teams that are interdisciplinary in nature and include faculty members from the Biomedical Engineering Department and clinical faculty from the Keck School of Medicine.
The Institute supports projects that involve medical doctors and engineers or scientists that create nano-medicine diagnostics or therapies for cancer. The program emphasizes work that will rapidly move into clinical tests and application.
CTIP helps innovators overcome commercialization challenges for pediatric medical devices, including support in the areas of manufacturing processes, intellectual property, regulatory oversight, clinical trial design and commercialization partnerships.
Innovation Node-LA is a collaboration between USC, UCLA, and Caltech focused on teaching entrepreneurial scientists and engineers the skills needed to bring proprietary technology to market. IN-LA provides programs in the Lean Startup methodology as developed by the National Science Foundation I-Corps program, focusing on hypothesis-driven business models and broad customer discovery.